logo
Social Withdrawal in Aging Tied to Shifts in Brain Networks

Social Withdrawal in Aging Tied to Shifts in Brain Networks

Medscape04-06-2025
There is a natural decline in sociability as a result of aging influenced by brain changes, new research shows.
'Our study suggests that age-related changes in the functional wiring of the brain may impair certain abilities needed to maintain social relationships,' the study's lead study author Yuet Ruh Dan, Duke-National University of Singapore Medical School, told Medscape Medical News .
The findings were published online on May 28 in PLOS One .
Sociability Critical to Health
Sociability, which is the capacity to communicate effectively, be socially assertive, and to manage emotions, is 'critical' for maintaining and promoting health, especially as we age, said Dan.
Research has linked sociability to increased functional connectivity in and between intrinsic brain networks. Overall, the default mode network (DMN), ventral attention network, and limbic structures have been the most strongly correlated with sociability.
The aging process also involves changes in intrinsic brain networks. Studies have shown that aging results in lower within-network connectivity, as well as greater between-network connectivity.
For example, Dan noted that connectivity between the frontoparietal and DMNs decreases with age change that has been linked to poorer self-esteem and memory. Meanwhile, connectivity between the limbic and insular regions increases with age and has been shown to activate in situations involving social exclusion, she added.
'Intuitively, poorer self-esteem and an increased sensitivity to exclusion may be linked to a decreased ability to communicate with others and regulate our emotions,' she said.
This study is among the first — if not thefirst — to directly examine the relationship between age-related changes in functional connectivity and sociability, Dan added.
The study included 196 healthy participants aged 20-77 years (mean age, approximately 38 years), with 34.2% identifying as female, drawn from the Leipzig Study for Mind-Body-Emotion Interactions dataset. For the analysis, researchers grouped participants into 5-year age brackets (20-25, 25-30, etc.), Dan said.
In addition, the researchers obtained resting-state functional MRI data. Participants completed the sociability subscale of the Trait Emotional Intelligence Questionnaire Short Form.
This six-question subscale measures social awareness, emotional management, communication effectiveness, and participation in social situations. The questionnaire is scored on a 7-point Likert scale ranging from 1 (completely disagree) to 7 (completely agree), with higher scores indicating higher levels of sociability.
Researchers also collected data using the NEO Five-Factor Inventory (NEO-FFI), which measures neuroticism, extraversion, openness to new experiences, agreeableness, and conscientiousness. They found a strong positive correlation between sociability and extraversion ( P < .001), highlighting a significant link between the two traits.
Researchers conducted network-based analyses to identify patterns of resting-state functional connectivity, grouping the data into an age-positive network (APN), which showed a positive correlation with age, and an age-negative network (ANN), which showed a negative correlation.
'Essentially, we found that with increased age, there is a group of functional brain networks that become more interconnected and a group that becomes less interconnected,' said Dan.
The subcortical-parietal connectivity and the within-limbic connectivity were the most negatively correlated in the ANN, while limbic-insular connectivity was the strongest positive correlation within the APN.
Within the positive connectivity network, ventral attention-somatomotor connectivity had the strongest correlation with age. Frontoparietal-DMN connectivity was the most negatively correlated with age.
Decreased Connectivity, Sociability
Both ANN and APN may contribute to decreased sociability, but it's not yet clear which plays the more dominant role, Dan said.
However, she and her colleagues have some theories. They propose that reduced connectivity between the frontoparietal and DMN regions may be linked to impaired cognition and lower self-esteem, 'thereby resulting in impaired social assertiveness, emotional regulation skills, and reduced sociability.'
Decreased connectivity of these regions could be linked to decreased sociability through impaired executive processing, they noted.
The study illustrates that as we age, 'it may not be just a lack of social contact opportunities that prevents us from forming and maintaining relationships but also an inherent change in the brain's functional wiring,' Dan said.
A mediation analysis showed the effect of age on sociability was fully mediated via both APN and AAN.
'Generally, these statistical results meant that the networks that become more connected, for example APN, as well as less connected, for example, ANN, with age can explain decreased sociability seen across the lifespan,' said Dan.
Dan emphasized that sociability is just one factor related to loneliness — and one that is relatively easy to measure — whereas loneliness itself is a far more complex and deeply subjective experience.
'Intuitively, people with lower sociability scores may be more likely to be lonely, as they may find it harder to maintain relationships. In this sense, increased sociability may be a risk factor for increased loneliness with age.'
Dan said she hopes these preliminary findings will spur more longitudinal research into these relationships and help inform efforts to support healthy aging.
She noted the importance of physicians recognizing that declining sociability may be a natural part of aging. 'Greater emphasis should be placed on community-based health promotion efforts,' she said.
The investigators did not analyze NEO-FFI personality trait variables, so 'we can't draw any conclusions about whether they were related to changes in brain connectivity or sociability,' Dan said.
She also noted that the sample was heavily skewed toward younger participants, which may limit the reliability of the findings for older adults. Additionally, grouping subjects into 5-year age bins may have introduced 'noise' into the statistical models.
Other limitations included an all-European study sample, and collection of sociability data exclusively via self-report, which may be less reliable than more objective measures like social network size.
Interpret With Caution
Commenting for Medscape Medical News , Dirk Scheele, PhD, professor of social neuroscience, Ruhr University Bochum, Bochum, German, said the paper addresses a 'relevant' topic.
'The general question of how social interactions and the desire for social engagement change with age is undoubtedly important, particularly given strong evidence that the risk of social isolation and loneliness increases with advancing age,' he said.
However, the underlying neural mechanisms remain 'surprisingly unclear,' he said. 'For example, no study to date has directly compared the neural substrates of loneliness or social isolation between younger and older adults.'
Although the study 'has the potential to inspire novel research questions,' its findings should be interpreted with 'considerable caution' due to several limitations, he said.
'Most notably, it's an entirely exploratory study without preregistration, and its cross-sectional design prevents conclusions about causal relationships,' he added.
Scheele also noted the 'sociability' construct was derived from a subscale of a questionnaire and 'encompasses multiple facets, such as emotion regulation and social awareness, that may belinked to distinct neural mechanisms.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Family of Long Island man killed in MRI machine mishap while wearing 20-pound chain poised to sue: ‘Ensure accountability'
Family of Long Island man killed in MRI machine mishap while wearing 20-pound chain poised to sue: ‘Ensure accountability'

New York Post

timea minute ago

  • New York Post

Family of Long Island man killed in MRI machine mishap while wearing 20-pound chain poised to sue: ‘Ensure accountability'

The family of a Long Island man who was killed when he was violently yanked into an MRI machine by a 20-pound chain around his neck hired an attorney in a likely precursor to a lawsuit. Keith McAllister, 61, was sucked into the magnetic force of an MRI machine at Nassau Open MRI on July 16, later suffering three heart attacks and dying from his injuries. Michael Lauterborn, an attorney for McAllister's widow Adrienne Jones-McAllister, said the family is now seeking 'accountability' for the freak accident. Advertisement 3 Keith McAllister, 61, suffered multiple heart attacks after he was sucked into an MRI machine by his 20-pound metal chain. Facebook/Karim McAllister 3 The MRI machine could have pulled McAllister with enough force to snap his neck, an expert told The Post. Brigitte Stelzer 'This heartbreaking incident highlights the critical importance of safety protocols in medical imaging facilities,' Lauterborn, an attorney with Cheung & Laterborn, said in a statement. 'The family and our legal team are dedicated to assisting the appropriate authorities in their investigation and in efforts to ensure accountability and prevent similar tragedies in the future.' Advertisement The attorney said the family is 'devastated and seeking answers' and called for privacy as they await further information. 3 Nassau Open MRI has not responded to multiple requests for comment. Brigitte Stelzer Jones-McAllister told local news network News 12 Long Island that her husband had been let into the exam room by a technician to help her get back on her feet at the end of an appointment. Advertisement McAllister wore the massive necklace as part of his weight training, his wife told the outlet. Jones-McAllister said she and a technician had struggled to try to free McAllister from the machine for almost an hour. Nassau Open MRI has not responded to multiple requests for comment.

AI model from Microsoft and UW maps out breast cancer in MRIs with unprecedented accuracy
AI model from Microsoft and UW maps out breast cancer in MRIs with unprecedented accuracy

Geek Wire

time31 minutes ago

  • Geek Wire

AI model from Microsoft and UW maps out breast cancer in MRIs with unprecedented accuracy

An AI model from researchers at the University of Washington, Microsoft's AI for Good Lab, and Fred Hutchinson Cancer Center creates heatmaps highlighting areas of concern on breast MRI scans. The top row is the original MRI. The second row shows the results from the new tool, compared to other models. (Figure from Oviedo et al in Radiology). New research shows how AI technology can spot breast cancer in MRI scans more accurately than current digital methods, while also pinpointing exactly where suspicious tissue is located — a breakthrough that could make the sensitive screening tool available to more women. The system takes a novel approach by learning what normal breast tissue looks like, then flagging anything unusual, which is the opposite of how cancer-detection AI has typically been built. When it identifies potential cancer, it creates a visual heatmap showing radiologists precisely where to look. Researchers with the University of Washington, Microsoft's AI for Good Lab, and Seattle's Fred Hutchinson Cancer Center were the lead collaborators on the study. Their results were recently published in Radiology, a journal of the Radiological Society of North America. They trained their AI model on roughly 9,500 MRIs collected at the UW between 2005 and 2022. The innovation could help expand access to breast MRI screening, which is more sensitive than mammography but currently limited primarily to high-risk patients due to cost and efficiency concerns. 'We're hoping to be able to offer breast MRI to more women than we do nowadays because it is a really sensitive breast screening tool,' said Savannah Partridge, a UW professor of radiology. 'But to do that, we're looking at how do we scale?' The strategy for building the model flipped the traditional approach on its head. Instead of learning to detect scans that are positive for cancer, the model was trained to recognize normal, or benign, images and then flag MRIs that included abnormal cells. The approach, called 'anomaly detection,' makes sense given that researchers have many more non-cancerous images than those showing disease, said Partridge, 'so we're able to leverage our data more efficiently.' An essential feature of the new tool is that it creates a heatmap overlaying the image, visually highlighting the area of concern. Other technologies sometimes indicate only whether cancer was detected in an MRI, but not precisely where it was found. 'Our model provides an understandable, pixel-level explanation of what's abnormal in a breast,' said Felipe Oviedo, a senior research analyst at Microsoft's AI for Good Lab, in a statement. The AI analysis could help radiologists prioritize cases that need quicker attention, guide providers in additional imaging, or indicate an area that requires a biopsy. The tool is not ready for use in clinical settings. Researchers are planning additional studies to see how the technology performs against radiologists reviewing the same images to better understand its benefits. Partridge, who is the UW's research director of breast imaging and the past associate director of cancer imaging at Fred Hutch, said the collaboration with Microsoft gave her the chance to be closely involved with the creation of the algorithm, providing insight into how it was built and behaved. Still, Partridge wants to proceed with caution when adopting AI for healthcare, ensuring that any clinical tool provides trustworthy, useful information that supports radiologists, rather than complicating their work. 'It's not do you use [AI], or do you not, but how do you use it?' she said. 'How do you use it appropriately and safely?' Additional authors of the study, which was titled 'Cancer Detection in Breast MRI Screening via Explainable AI Anomaly Detection,' are Anum Kazerouni, Philipp Liznerski, Yixi Xu, Michael Hirano, Robert Vandermeulen, Marius Kloft, Elyse Blum, Adam Alessio, Christopher Li, William Weeks, Rahul Dodhia, Juan Lavista Ferres and Habib Rahbar. Their affiliations include the UW, Microsoft, Fred Hutch, Michigan State University, University of Kaiserslautern-Landau, Berlin Institute for the Foundations of Learning and Data, and Technical University of Berlin.

Imaging Boom Drives Cancer Detection and Healthcare Growth
Imaging Boom Drives Cancer Detection and Healthcare Growth

Time Business News

time2 hours ago

  • Time Business News

Imaging Boom Drives Cancer Detection and Healthcare Growth

Cancer is a condition where cells in a specific part of the body start multiplying out of control, often clumping together to form tumors. Doctors can identify cancer using different kinds of tests, including imaging scans, endoscopy, tumor marker tests, biopsies, complete blood counts, and MRI scans. Major growth factor consist of large number of clinics have adopted tools for cancer detection like MRI, CT-scans and other. This has led to growth in healthcare sector and global economy. It is also a milestone for healthcare services. Key Growth Drivers and Opportunities Growing Incidence of Cancer: The increasing prevalence and incidences of various types of cancer like lung cancer and breast cancer, help the cancer diagnostics market to grow significantly during the forecast period. According to estimates, 1 in 100 (or 1% yearly) of those 70 years of age or over lost their lives to cancer in 2019. Overall death toll is rising in tandem with the world's population growth. From roughly 46 million in 1990 to 56 million in 2019, there have been more fatalities. Most cancer deaths occur in elderly adults. Rising Expenditure of Healthcare: The cost estimates cover both prescription medications taken by mouth and medical treatments for cancer. The most expensive medical services nationally were linked to non-Hodgkin lymphomas, as well as cancers of the prostate, lung, colon, and female breast. Medical services care costs, which comprise Medicare payments as well as patient obligations for all billed medical services, such as hospitalizations, outpatient hospital services, physician/supplier services, infusion or injectable drug, durable medical equipment, and hospice care, were estimated from Medicare Parts A and B claims. Challenges The implementing cancer diagnostics can require significant upfront investment, including the cost of the software itself, customization, and integration with existing systems. This can be a barrier for smaller hospitals with limited budgets. The regulatory landscape for cancer diagnostics is constantly evolving, with new guidelines and requirements emerging regularly. Keeping up with these changes and adjusting reporting practices accordingly can be a daunting task for companies Innovation and Expansion Guardant, Boehringer Team Up on HER2 NSCLC Liquid Biopsy In December 2024, the Guardant Health, Inc. announced a partnership with Boehringer Ingelheim aimed at obtaining regulatory approval and advancing the commercialization of the Guardant360 CDx liquid biopsy. This partnership is all about using liquid biopsy as a companion diagnostic (CDx) for zongertinib. Zongertinib is a new type of drug called a covalent tyrosine kinase inhibitor (TKI) designed to specifically target HER2 in non-small cell lung cancer (NSCLC), while minimizing the impct on the epidermal growth factor receptor (EGFR). GE, GenesisCare Partner to Tackle Cancer and Heart Disease In November 2020, GE Healthcare entered into partnership with GenesisCare to improve patient outcomes for the two biggest health burdens globally, cancer and heart disease. GE Healthcare will provide CT, MRI, PET/CT, SPECT, digital mammography, and ultrasound equipment to GenesisCare's 440+ cancer and cardiovascular disease treatment centers across Australia, the US, the UK, and Spain This partnership is all about boosting how accurately we can diagnose conditions and making treatment plans smoother, all thanks to state-of-the-art imaging tech. With GE Healthcare's innovative tools, GenesisCare can really speed up spotting issues early on and providing tailored care for folks dealing with cancer or heart-related conditions. Inventive Sparks, Expanding Markets The Key players in the global cancer diagnostics market includes, Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company among others. As major key players, they're effectively striving in innovation to make sure consumers globally can benefit from modern healthcare tech and to really elevate the overall experience for patients everywhere. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store